Skip to main content

Treatment Advances For Slow-Growing Non-Hodgkin Lymphomas

March 29, 2019

Topics Covered

We invite you to learn more about:

  • The importance of knowing your non-Hodgkin lymphoma (NHL) subtype
  • Current and emerging therapies
  • Managing side-effects of treatment
  • The benefit of discussing quality-of-life concerns with your healthcare team

Speakers

Jonathon B. Cohen, MD, MS
Assistant Professor, Hematology and Medical Oncology
Director, Lymphoma Clinical Trials Working Group
Winship Cancer Institute of Emory University
Atlanta, GA

Program Materials

Program Support

Support for this program is provided by Bristol-Myers Squibb; Genentech and Biogen; Pharmacyclics, an AbbVie company and Janssen Biotech.

< Back to Webcasts

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.